After more than 15 years as President and CEO, Per Wallentin will step down from his role at Knowit. Per will remain in his current position until August 1, 2026. A process to recruit a new President and CEO will now be initiated.
After more than 15 years as President and CEO, Per Wallentin will step down from his role at Knowit. Per will remain in his current position until August 1, 2026. A process to recruit a new President and CEO will now be initiated.
Following a long and successful period, the Board of Directors, in dialogue with Per Wallentin, has concluded that it is a natural step to initiate a leadership transition. Knowit operates in a market characterized by rapid technological development, not least within AI, and combined with a changing macro environment, this is an appropriate time for new leadership to take the company into its next phase.
The Board of Directors has appointed Fredrik Ekerhovd, currently Head of Knowit Solutions, as interim President and CEO effective August 1, 2026. Fredrik Ekerhovd has extensive experience within Knowit and will ensure continuity in the business.
“During Per’s many years as CEO, Knowit has developed strongly, achieving significant growth both organically and through acquisitions, while strengthening its market position. Today, Knowit is well positioned for the future. I would like to extend my sincere thanks to Per for his leadership, dedication and the value he has created during his time as CEO,” says Chairman of the Board Per Sjöstrand.
“When I look back on my years at Knowit, I feel above all a deep sense of gratitude. Together with many dedicated colleagues, we have built Knowit into a leading company, with a strong corporate culture and clear values. It has been a journey characterized by strong commitment, an entrepreneurial spirit and continuous development. At the same time, it feels like a natural point in time to hand over. Knowit is a stable company with an important role going forward, and I am confident that the journey will continue with full momentum,” says Per Wallentin.